LFG
COLL icon

Larson Financial Group’s Collegium Pharmaceutical COLL Stock Holding History

Larson Financial Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$59 – 3482
2025
Q2 		$59 Hold
2
– – ﹤0.01% 3219
2025
Q1 		$60 Hold
2
– – ﹤0.01% 2975
2024
Q4 		$57 Sell
2
-277
-99% -$9.16K ﹤0.01% 2683
2024
Q3 		$10.8K Buy
279
+277
+13,850% +$9.88K ﹤0.01% 1455
2024
Q2 		$64 Buy
+2
New +$69 ﹤0.01% 2328

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Larson Financial Group's COLL Position: Q3 2025 in Review

Larson Financial Group sold out of Collegium Pharmaceutical (COLL) in Q3 2025, closing a stake of 2 shares — an estimated $59 sold.

Larson Financial Group first reported a position in COLL in Q2 2024 and held it in 5 quarters. The position peaked at $10.8K in Q3 2024. 244 funds tracked by Wall St. Rank hold COLL as of Q3 2025.

  • Larson Financial Group reported no remaining Collegium Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Larson Financial Group sold 2 Collegium Pharmaceutical shares in Q3 2025, an estimated $59.
  • Larson Financial Group first reported a position in Collegium Pharmaceutical in Q2 2024 and held it in 5 quarters.
  • Larson Financial Group's Collegium Pharmaceutical position peaked at $10.8K in Q3 2024.
  • 244 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2025.

Based on Larson Financial Group's 13F filing for Q3 2025, filed 14 Nov 2025.